| Phoebe Shackelford, PHARMD | |
|
1808 Albany St, Beech Grove, IN 46107-1404 | |
| (317) 786-1037 | |
| Not Available |
| Full Name | Phoebe Shackelford |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1808 Albany St, Beech Grove, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629351366 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26023214A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Phoebe Shackelford, PHARMD 1808 Albany St, Beech Grove, IN 46107-1404 Ph: () - | Phoebe Shackelford, PHARMD 1808 Albany St, Beech Grove, IN 46107-1404 Ph: (317) 786-1037 |
News Archive
Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier - a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.
Today, Ferring Pharmaceuticals and MSD, via its MSD for Mothers initiative, announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program (HRP) at the World Health Organization (WHO).
AppDynamics, Inc.™, the next-generation Application Performance Management (APM) company, today announced that it has closed its Series B round of financing, and had raised $11 million. The round is co-led by existing Series A investors Lightspeed Venture Partners and Greylock Partners, and will support the company's continued expansion as it takes advantage of market demand for next-generation application performance management (APM). To date, the company has received $16.5 million in venture funding.
e-Therapeutics plc announces that it has started a randomised double-blind controlled phase IIb trial of ETS6103 in major depressive disorder.
› Verified 5 days ago
Nicole Anne Magsambol Apa, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1808 Albany St, Beech Grove, IN 46107 Phone: 317-786-1031 | |
Derek Everhart, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1715 Main St, Beech Grove, IN 46107 Phone: 317-784-9037 | |
Eric Fisher, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1808 Albany St, Beech Grove, IN 46107 Phone: 317-786-1031 Fax: 317-786-1036 | |
Mrs. Jennifer E Carson, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1808 Albany St, Beech Grove, IN 46107 Phone: 317-786-1031 Fax: 317-786-1036 | |
Kelsey Kurey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1808 Albany St, Beech Grove, IN 46107 Phone: 317-786-1031 | |
Krysten Raeanne Harlan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1715 Main St, Beech Grove, IN 46107 Phone: 317-784-9037 Fax: 317-786-2944 |